Hpc Biosciences - Due diligence report

A 360° intelligence report on Hpc Biosciences: trust score, financial health, credit view, compliance, directors, growth and distress signal…

2002-01-29 Delhi, Delhi Active Listed Active Non-Compliant
Share
Connect MCP
HB Hpc Biosciences
Full Due-Diligence Report + Documents
  • Unlock all financial figures & 5-year trends
  • Full trust, health & credit-risk scores
  • Director details, charges & MCA documents
₹700 ₹449 Save ₹251 excl. GST
Or from ₹279/report with credits View credit packages
Company Credits – Starter
  • One credit unlocks this full due-diligence report
  • Use across any company’s report, anytime
  • Credits valid for 12 months
× ₹700 ₹279 = ₹2,790 60% off
Choose your own credit amount View credit packages

Hpc Biosciences — 360° Intelligence Report

Generated from MCA filings & public records
64/100
Trust Score
Moderate

Hpc Biosciences is assessed as Moderate with a Trust Score of 64/100. Hpc Biosciences is an active public limited indian non-government company incorporated in 2002, operating in the Agriculture sector. Reported revenue has declined across its recent filed years. It was profitable in its latest filed year. Based on MCA filings and public records, it currently shows a high compliance risk and low financial risk profile.

Report generated on 27 Sep 2026 from the latest processed filings. Hpc Biosciences Limited snapshot & full profile →

Financial Health › Strong
Overall Assessment CautionWeakNeutralGoodStrong Good
Compliance › Caution

Automated indicators derived from public MCA / GST / EPFO records - not a credit rating, not investment, legal or financial advice. Spotted an inaccuracy? Report an error.

02

Score Card

Higher is safer · rule-based & explainable
Trust ScoreModerate
64/100
Overall counterparty trust - the headline number of this report.
Compliance ScoreCaution Indicated
25/100
Statutory standing - status, filings, auditor, MSME and litigation.
Financial Health ScoreLow Risk
90/100
Profitability, leverage and liquidity from filed statements.
Credit Risk ScoreLow Risk
90/100
Debt capacity, gearing and security cover for lenders.
Director Stability ScoreModerate
55/100
Board strength, DIN status, churn and network.
Growth ScoreModerate
65/100
Revenue, profit, asset and hiring momentum.
Distress ScoreLow Risk
80/100
Early-warning signals - higher means fewer warnings.
03

Financial Intelligence Dashboard

Standalone · 5 filed year(s)

Unlock the full 5-year financial dashboard with charts and year-wise figures.

Get full access

Scores and observations on this page are already computed from the real filings - only the underlying figures are locked.

04

Credit & Compliance Intelligence

Why the scores are what they are
Credit Risk Score: 90/100 Low Risk
  • Liabilities ≈ 38% EBITDA - serviceable.
  • No open charges - unencumbered balance sheet.
  • Working-capital cover adequate.
  • Profitable - internal accruals available.

Charges position: 0 open (-) · 0 satisfied (-).

Compliance Score: 25/100 Caution Indicated
  • Company status is Active as per MCA.
  • Marked ACTIVE non-compliant (INC-22A).
  • Last balance sheet is for Mar 2021 - filings overdue.
  • Flagged by authority: SEBI, BSE.
05

Director Intelligence

Stability score: 55/100
NameDIN / PANDesignationAppointedTenureDIN status
MUMATAJ 01234567 Director 01/04/2018 6 yrs Approved
KISHORI PRASAD GUPTA 01234567 Director 01/04/2018 6 yrs Approved
CHANDAN MANDAL 01234567 Director 01/04/2018 6 yrs Approved
RADHA KUMARI 01234567 Director 01/04/2018 6 yrs Approved
  • 4 directors on the board.
  • CHANDAN MANDAL has DIN status "Deactivated due to non-filing of DIR-3 KYC".
  • Stable board - no exits in 3 years.
  • Average tenure above 5 years.
Director & KMP remuneration (FY 2017)
NameDesignationTotal remuneration
A K SharmaManaging Director2.4 cr
R MehtaWhole-time Director1.6 cr
S IyerCFO95.0 L

Remuneration is disclosed in the latest annual return. Unlock full report

06

Ownership & Group Intelligence

As per FY 2021 annual return
Promoter holding
64.27%
Public / other holding
35.73%
Equity shares
12,45,67,890
Equity paid-up
124.5 cr
Promoters on record
4
Ultimate holding entity
-
Subsidiaries
-
Group entities
-
Capital events
14 allotment(s) · 0 transfer(s)

Promoters hold a minority stake - exact percentages are part of the full report.

Full shareholding pattern, group structure & capital events →

07

Risk Intelligence Center

Growth 65 · Distress 80
Growth signals & trust indicators
Latest year revenue grew 1.42.
Profit expanded 2.1x year-on-year.
Net margin improved to 24%.
Operating for 24+ years.
Distress signals & risk flags
Statutory filings appear overdue.
Compliance score is weak (25/100).
08

Stakeholder Verdicts

Vendor · Banker · Investor
Vendor due diligence53/100
Review suggested
Suitability as a supplier / customer counterparty.
  • Check the compliance flags before onboarding.
  • 1 distress signal(s) - see Risk Center.
  • Financial filings available for verification.
Banker assessment74/100
Favourable lending indicators
Indicative lending comfort for banks, NBFCs and trade credit.
  • Debt capacity assessed from filed statements.
  • No existing security registered - first-charge position available.
  • Compliance gaps should be priced into terms.
Investor view74/100
Positive growth indicators
Growth quality and scalability through an investor lens.
  • 3 growth signal(s) detected.
  • Margin and return trends computable from filings.
  • Management churn warrants questions.
09

MCA Filings & Events Timeline

Latest 15 events
05 Sep 2022
Director appointed
CHANDAN MANDAL (Additional Director)
Director appointed
RADHA KUMARI (Additional Director)
Director ceased
TARUN CHAUHAN
Director ceased
MADHU ANAND
22 Sep 2021
Last AGM held
Annual general meeting
31 Mar 2021
Latest balance sheet
Filed with ROC
31 Jan 2020
Director ceased
NEHA DEWAN
13 Mar 2018
Director appointed
KISHORI PRASAD GUPTA (Director)
Director ceased
VIRENDER KHANNA
03 Mar 2016
Director appointed
MUMATAJ (Director)
13 Jul 2015
Director ceased
SAKSHI SAXENA
14 Jan 2015
Director ceased
SUSHIL RAO KUMAR
04 Oct 2013
Director ceased
ARUN KUMAR GUPTA
20 Mar 2013
Securities allotted
4560000 Equity Shares Without Differential Rights - 15.96 cr raised
14 Mar 2013
Securities allotted
4560000 Equity Shares Without Differential Rights - 15.96 cr raised
10

Key Observations

Auto-generated from the data above
Revenue declined 0.86 over the last 4 financial year(s).
Net profit margin moved from 61% to 38%.
Net worth is positive.
4 active director(s) / partner(s); review board churn before relying on management continuity.
Promoters hold a minority stake as per the FY 2021 annual return.
Director / KMP remuneration is disclosed in the latest annual return - exact figures available in the full report.
Capital has been raised through 14 security allotment(s) - amounts available in the full report.
11

Peers & Related Companies

Full peer comparison →
CompanyCINLocation
Sanjevani Goats U74999WB2018PTC224743 Kamarkundu, West Bengal, India
Kurkenmutty Estates Private Limited U51226KA2004PTC033423 Bangalore, Karnataka, India
Mullai Sustainable Agriculture Producer Company Limited U01403TZ2015PTC021594 Dindigul, Tamil Nadu, India
Shubham Pulses Industries India Private Limited U15313CT2006PTC020056 Abhanpur, Chattisgarh, India
Kamakhyabari Tea Co Pvt Ltd U01132WB1982PTC035556 Kolkata, West Bengal, India
Elegant Flower Company Private Limited U01122WB2001PTC094021 North-24-Pgs, West Bengal, India
Indian Natural Farmers Producer Company Limited U01403TN2014PTC096740 Little Kanchipuram, Tamil Nadu, India
Blupex Vinimoy Pvt. Ltd. U51909WB1994PTC063551 New Town, West Bengal, India
12

Who Uses This Report

CA · CS · Banker · Investor · Vendor
Chartered Accountants (CA)

Verify Hpc Biosciences before audits and certifications: compliance score 25/100, filing history, auditor history and charge records in one place - instead of pulling each MCA form separately.

Company Secretaries (CS)

Track statutory health of Hpc Biosciences: ACTIVE compliance status, annual-return recency, director DIN status, board churn and the events timeline - the inputs for secretarial audits and due-diligence certificates.

Bankers & NBFCs

Current banker verdict: Favourable lending indicators. Credit risk score 90/100, existing charge position and lender relationships - a first-pass credit memo before formal appraisal.

Investors & Analysts

Investor view: Positive growth indicators. Growth score 65/100, margin trends, ownership structure and peer set for Hpc Biosciences - screening before a deeper diligence.

Vendors & Procurement Teams

Vendor verdict: Review suggested. Trust score 64/100, distress signals and MSME payment-delay disclosures - know whether Hpc Biosciences pays its suppliers before you extend credit terms.

Lawyers & Compliance Teams

Litigation footprint (no cases on record), regulatory flags, charge documents trail and director networks for Hpc Biosciences - groundwork for KYC, onboarding and disputes.

13

Frequently Asked Questions

Is Hpc Biosciences an active company?

Hpc Biosciences has MCA status “Active” with a compliance score of 25/100 (Caution Indicated).

Is Hpc Biosciences financially healthy?

Hpc Biosciences has a Financial Health Score of 90/100 (Low Risk) based on its filed financial statements.

Should I do business with Hpc Biosciences?

Its overall Trust Score is 64/100 (Moderate). Vendor verdict: Review suggested. Review the risk flags in the Risk Intelligence Center before deciding.

Who controls Hpc Biosciences?

Promoters hold a minority stake - exact percentages are in the full report. 4 active director(s) are on record.

Does Hpc Biosciences have loans or charges against its assets?

No charges are registered against this company - an unencumbered balance sheet.

Is Hpc Biosciences up to date with its ROC filings?

Marked ACTIVE non-compliant (INC-22A). Overall compliance score: 25/100 (Caution Indicated).

Is it risky to lend to Hpc Biosciences?

Its Credit Risk Score is 90/100 (Low Risk). Banker verdict: Favourable lending indicators.

Disclaimer: This report is generated automatically from MCA filings and public records as available in our system at the time of the last update. Scores, bands and verdicts are rule-based derived indicators of the underlying data - they are opinions generated by an algorithm, not statements of fact about the company, and are not credit ratings (within the meaning of SEBI regulations), audits, or investment, legal or financial advice. Verify from official sources and consult a qualified professional before any business, lending or investment decision. If you represent this company and believe any information is inaccurate or outdated, report it here and we will review promptly.